BCL2 amplification and copy number gains are uncommon in breast tumors, and there is no linear correlation between Bcl-2 gene transcripts and protein levels, thus pointing to post-transcriptional regulation of these proteins [17]. The gene discussed is BCL2; the disease is breast neoplasm.